Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GHSR | Q92847 | 1/20 | 0.32 |
| ▸ | RAB9A | P51151 | 1/20 | 0.31 |
| ▸ | TACR1 | P25103 | 1/20 | 0.31 |
| ▸ | ACHE | P22303 | 1/20 | 0.31 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5230927 | 0.83 | GHSR (0.45) | GHSR | |
| SCHEMBL5228589 | 0.83 | GHSR (0.45) | GHSR | |
| SCHEMBL5229201 | 0.80 | GHSR (0.38) | GHSRSIGMAR1 | |
| SCHEMBL5226491 | 0.79 | ACHE (0.38) | ACHE | |
| SCHEMBL5228646 | 0.79 | ACHE (0.38) | ACHE | |
| SCHEMBL6638381 | 0.76 | GHSR (0.39) | GHSRRAB9ATACR1 | |
| SCHEMBL6640209 | 0.76 | GHSR (0.42) | GHSRTACR1 | |
| SCHEMBL5228930 | 0.75 | KDM4E (0.35) | GHSR | |
| SCHEMBL3840114 | 0.75 | GHSR (0.55) | GHSR | |
| Hydrochloric Acid SCHEMBL7535223 | 0.75 | GHSR (0.35) | GHSRRAB9ATACR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6429313-B2 | Dipeptide derivatives | PFIZER INC. | 2002-08-06 | — | — | US | disclosed |
| US-20020065284-A1 | Dipeptide derivatives | CARPINO PHILIP ALBERT (US) | 2002-05-30 | — | — | US | disclosed |
| US-20020002165-A1 | Dipeptide derivatives | CARPINO PHILIP ALBERT (US) | 2002-01-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020002165-A1 | Dipeptide derivatives | GIPR, GHRHR, GHSR | GHSR 3/4885RAB9A 4472/4885TACR1 218/4885 |
| US-20020065284-A1 | Dipeptide derivatives | GIPR, GHRHR, GHSR | GHSR 3/4885RAB9A 4472/4885TACR1 218/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.